Union Medical uses Photon Control’s optical sensors in medical device
Category: #health  By Mateen Dalal  Date: 2019-12-17
  • share
  • Twitter
  • Facebook
  • LinkedIn

Union Medical uses Photon Control’s optical sensors in medical device
  • The optical sensors are designed to integrate into Union Medical’s Neo Thermos
     
  • Neo Thermos is utilized to treat tumors without affecting the normal cells

Photon Control Inc., a developer and supplier of optical measurement technologies for semiconductor companies has recently announced that it will be expanding its addressable market with the launch of a new product by Union Medical Co. Ltd., a Korean-based manufacturer that produces electrosurgical, laser and various other aesthetic equipment.

The optical sensors and systems of Photon Control have been specially designed to be integrated into a medical device for high-frequency hyperthermia treatment of cancer, produced by Union Medical. The medical device is called Neo Thermos and is used to treat the tumors without having to affect the normal cells.

The temperature sensor systems made by Photon Control are generally used to monitor the temperature of the patients during their treatment. The fiber optic technology of the device is known to be immune to the radio frequency that is generated from the device.  

The Chief executive officer of Photon Control, Nigel Hunton stated that the company has taken the products to the medical industry as part of its growth strategy of willing to increase the addressable market. He further added that the expansion towards the medical sector will confirm Photon’s ability to influence their technology in several markets that share similar features with their core business.

The company has a strong market position within the semiconductor industry wherein it has been aiming to build on the existing technology as well as developing a know-how to be able to enter the near-adjacent markets.

Union Medical’s Chief Technology Officer, Bong Suek Kim commented that the firm is looking forward to working with Photon Control on Neo Thermos, an innovative device made to treat cancer without affecting the normal cells.

Kim added that Photon Control has had a proven solution within the semiconductor industry for years with a high level of reliability, repeatability, and accuracy of all their temperature systems and sensors.

 

Source Credit- https://www.photoncontrol.com/news-release/photon-control-expands-addressable-market-with-new-medical-application/

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

Snapchat announces the launch of in-app TikTok competitor Spotlight
Snapchat announces the launch of in-app TikTok competitor Spotlight
By Mateen Dalal

Snapchat, an American multimedia messaging platform, has reportedly launched a new section of its application called Spotlight. The new feature will offer surface video content and will allow the company to compete with Chinese video sharing platform...

Google Pay updated to become an all-in-one-bank ahead of Plex launch
Google Pay updated to become an all-in-one-bank ahead of Plex launch
By Mateen Dalal

Google’s digital wallet and online payment system Google Pay has reportedly been updated with a bunch of new features, UI, and a logo. Sources with relevant information claimed that these changes are a result of huge upscaling of Google Pay as ...

Alibaba generates revenues worth USD 74 billion in Singles Day sale
Alibaba generates revenues worth USD 74 billion in Singles Day sale
By Mateen Dalal

Alibaba, a Chinese multinational technology company, has reportedly generated sales worth USD 74 billion in its post COVID-19 Singles’ Day shopping extravaganza. The recent development follows the company recently witnessing a 10% decline in it...